Myeloma Hematologist

Position Overview

The Division of Hematology and Hematologic Malignancies at the University of Utah and the Huntsman Cancer Institute is seeking to recruit a faculty member at the rank of Assistant or Associate Professor, DOQ, to be an integral member of the Plasma Cell Dyscrasia Program. The role focuses on clinical trial development and accrual of patients with multiple myeloma.

The candidate should have a superb clinical skill set with extensive experience treating patients with plasma cell dyscrasias, including smoldering myeloma, multiple myeloma, amyloidosis, and Waldenstrom macroglobulinemia. They should have a strong track record as a principal investigator on clinical trials and experience writing and leading investigator‑initiated trials with novel therapeutic approaches.

The ideal candidate will be highly collaborative, boosting the already strong clinical Plasma Cell Dyscrasia Program with a variety of research projects with high potential for clinical impact. They should also have experience supervising a multi‑disciplinary clinical staff, including advanced practice clinicians (APC), pharmacists, and clinical/research coordinators.

Candidates are expected to have a strong track record of cooperative group, investigator‑initiated, and industry‑sponsored trial participation, at least 3 years of clinical experience focused on treatment of patients with plasma cell dyscrasias, and a successful record of obtaining intra‑ and extramural funding from federal, foundation, and pharmaceutical sources. This position will practice primarily out of the Huntsman Cancer Institute and University of Utah Hospital.

MD or DO degree (or equivalent degree) with board certification in Hematology or Oncology, with or without a PhD; must possess or be eligible for a Utah Medical License; demonstrated initiative, curiosity, and capabilities within an academic environment.

The mission of the Division of Hematology and Hematologic Malignancies is to provide state‑of‑the‑art diagnostics and treatment in an environment of compassionate care to patients with hematologic cancer and non‑malignant hematologic conditions. The Division currently has 31 full‑time Clinical Faculty members engaged in several subspecialties and conducts a broad spectrum of clinical, translational, and basic research in Hematology.

The University of Utah and the Huntsman Cancer Institute are the only NCI‑designated Cancer Center in the Intermountain West. The research environment includes world‑class transgenic facilities, genome‑wide scanning technologies, drug development platforms, pharmacology, and toxicology. All clinical facilities are in close physical proximity to laboratories in the Huntsman Cancer Institute.

Apply online at . For inquiries, contact Dr. Douglas Sborov at Douglas.

Sborovh.edu
.

Department: Hematology (00847)
City: Salt Lake City, UT
Track: Track Dependent on Qualifications

The University of Utah is an affirmative action/equal opportunity employer and does not discriminate based on race, ethnicity, color, religion, national‑origin, age, disability, sex, sexual orientation, gender identity, gender expression, pregnancy, pregnancy‑related conditions, genetic information, or protected veteran's status. It complies with Title IX and 34 CFR part 106. For accommodations, contact the Office of Equal Opportunity and the Title IX Coordinator.